Cargando…

Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage

This cohort study of health claims data examines trends in testosterone prescriptions for older men in the US following 2014 changes to the US Food and Drug Administration’s stance on testosterone’s effects and safety risks.

Detalles Bibliográficos
Autores principales:	Everhart, Alexander, Harper, Katrina, Jeffery, Molly Moore, Levin, Zachary, Morden, Nancy E., Sankar, Ashwini, Karaca-Mandic, Pinar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482052/ https://www.ncbi.nlm.nih.gov/pubmed/34586370 http://dx.doi.org/10.1001/jamanetworkopen.2021.27349

Ejemplares similares

Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
por: McCoy, Rozalina G., et al.
Publicado: (2021)

Association of Health Insurance Literacy With Enrollment in Traditional Medicare, Medicare Advantage, and Plan Characteristics Within Medicare Advantage
por: Park, Sungchul, et al.
Publicado: (2022)

Medicare and Private Insurance Variations in New Medical Technology: The Case of Drug Eluting Stents
por: Bayindir, Esra Eren, et al.
Publicado: (2016)

Association Between New 340B Program Participation and Commercial Insurance Spending on Outpatient Biologic Oncology Drugs
por: Chang, Jessica, et al.
Publicado: (2023)

Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims
por: Jena, Anupam B, et al.
Publicado: (2014)

Comparison of the Pathway to Hospice Enrollment Between Medicare Advantage and Traditional Medicare
por: Ankuda, Claire K., et al.
Publicado: (2023)

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study
por: Jeffery, Molly Moore, et al.
Publicado: (2018)

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers
por: Lin, Dora H., et al.
Publicado: (2018)

Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs Medicare Advantage prescription drug plans
por: Newman, Terri Victoria, et al.
Publicado: (2022)

Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage
por: Barsky, Benjamin A., et al.
Publicado: (2022)

Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factors
por: Togun, Adeniyi T., et al.
Publicado: (2021)

Association of 3 CDC opioid prescription guidelines for chronic pain and 2 payer pharmacy coverage changes on opioid initiation practices
por: Togun, Adeniyi T, et al.
Publicado: (2021)

Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment before and after Implementation of Quality-Related Bonus Payments in 2012
por: Li, Pengxiang, et al.
Publicado: (2016)

Medicare Advantage Enrollment and Disenrollment Among Persons With Alzheimer Disease and Related Dementias
por: James, Hannah O., et al.
Publicado: (2023)

Use of High-Risk Medications Among Older Adults Enrolled in Medicare Advantage Plans vs Traditional Medicare
por: Figueroa, Jose F., et al.
Publicado: (2023)

Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis
por: Smoyer-Tomic, Karen E, et al.
Publicado: (2012)

Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009
por: Dalal, Anand A, et al.
Publicado: (2011)

National trends in emergency conditions through the Omicron COVID‐19 wave in commercial and Medicare Advantage enrollees
por: Stevens, Maria A., et al.
Publicado: (2023)

ROLE OF SOCIAL DETERMINANTS IN ENROLLMENT AND DISENROLLMENT IN MEDICARE INSURANCE PLANS IN OLDER MEXICAN AMERICANS
por: Kumar, Amit, et al.
Publicado: (2019)

The growing problem of co-treatment with opioids and benzodiazepines
por: Karaca-Mandic, Pinar, et al.
Publicado: (2017)

Comparison of Ambulatory Care Access and Quality for Beneficiaries With Disabilities Covered by Medicare Advantage vs Traditional Medicare Insurance
por: Johnston, Kenton J., et al.
Publicado: (2022)

Evaluation of Potentially Avoidable Acute Care Utilization Among Patients Insured by Medicare Advantage vs Traditional Medicare
por: Beckman, Adam L., et al.
Publicado: (2023)

Assessment of Unmet Health-Related Social Needs Among Patients With Mental Illness Enrolled in Medicare Advantage
por: Adepoju, Omolola E., et al.
Publicado: (2022)

Patterns of Comorbidity and Multimorbidity Among Patients With Multiple Sclerosis in a Large US Commercially Insured and Medicare Advantage Population
por: Dai, Dingwei, et al.
Publicado: (2022)

Characteristics of Hydroxychloroquine Dispensing in the United States, January to May 2020
por: Levin, Zachary, et al.
Publicado: (2021)

Risk Differential Between Medicare Beneficiaries Enrolled and Not Enrolled in an HMO
por: Eggers, Paul
Publicado: (1980)

Medicare Quality Improvement Organizations' Ambulatory Drug Therapy Improvement Activities and Partnerships With Medicare Part D Prescription Drug Plans and Medicare Advantage Plans
por: Schulke, David G., et al.
Publicado: (2007)

Cardiovascular risk prediction model and stratification in patients with type 2 diabetes enrolled in a Medicare Advantage plan
por: Caplan, Eleanor O, et al.
Publicado: (2021)

Medicare enrollment in health maintenance organizations
por: McMillan, Alma, et al.
Publicado: (1987)

Compared to commercially insured patients, Medicare advantage patients adopt newer diabetes drugs more slowly and adhere to them less
por: Flory, James H, et al.
Publicado: (2021)

Pre-Enrollment Reimbursement Patterns of Medicare Beneficiaries Enrolled in “At-Risk” HMOs
por: Eggers, Paul W., et al.
Publicado: (1982)

Real-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospective Observational Study
por: Dang-Tan, Tam, et al.
Publicado: (2019)

Increasing Trends in the Use of Hospital Observation Services for Older Medicare Advantage and Privately Insured Patients
por: Lind, Keith D., et al.
Publicado: (2017)

Can Insurance Market Competition Coexist With Provider Price Regulation? Evidence From Medicare Advantage
por: Berenson, Robert A., et al.
Publicado: (2019)

Cost-related delay in filling prescriptions and health care ratings among medicare advantage recipients
por: Parikh, Toral J., et al.
Publicado: (2019)

588. Retrospective Analysis of Clinical Characteristics and Treatment Patterns Among HIV Patients with Commercial and Medicare Advantage Health Insurance in the United States
por: Priest, Julie, et al.
Publicado: (2018)

Testosterone treatment and cardiovascular events in prescription database studies
por: Shores, Molly M
Publicado: (2018)

Effect of Medicare Advantage Payments on Dually Eligible Medicare Beneficiaries
por: Atherly, Adam, et al.
Publicado: (2005)

Who Enrolls in the Medicare Part D Prescription Drug Benefit Program? Medication Use Among Patients With Heart Failure
por: Eapen, Zubin J., et al.
Publicado: (2013)

Patient Perspectives on the Burden of Heart Failure with Preserved Ejection Fraction in a US Commercially Insured and Medicare Advantage Population: A Survey Study
por: Nguyen, Chi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_76dvbq9fetnqvk4d4c3ge9vtpj